TRETTEN
STN: 125398
Proper Name: Coagulation Factor XIII A-Subunit (Recombinant)
Tradename: TRETTEN
Manufacturer: Novo Nordisk Inc
Indication:
- Is indicated for routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.
Product Information
Supporting Documents
- Approval History, Letters, Reviews, and Related Documents - TRETTEN
- Supporting Documents older than three years - TRETTEN